Michigan telemedicine screening for glaucoma and other sight‑threatening eye problems
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine- SIGHT 2: A Pragmatic Randomized Trial
NA · University of Michigan · NCT06934577
This program tests whether a technology-enhanced telemedicine screening finds glaucoma, diabetic eye disease, and visually significant cataracts more often than a standard optometric exam for patients at a community health center.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 900 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Michigan (other) |
| Locations | 1 site (Flint, Michigan) |
| Trial ID | NCT06934577 on ClinicalTrials.gov |
What this trial studies
At a Federally Qualified Health Center in Flint, Michigan, patients eligible for routine eye care are assigned to either a standard optometric examination or a technology-enhanced screening protocol that uses digital imaging and telemedicine workflows. Imaging and measurements are reviewed remotely to identify glaucoma, diabetic retinopathy, and visually significant cataract. The study compares detection rates between the two approaches to see which method identifies more cases of these leading causes of blindness. Enrollment supports multiple languages and excludes patients with acute eye symptoms or cognitive impairment.
Who should consider this trial
Good fit: Adults receiving care at the participating Federally Qualified Health Center who speak one of the listed languages and do not have acute eye symptoms, recent severe vision loss, or cognitive impairment.
Not a fit: People with sudden severe eye pain, rapid vision loss within one week, new double vision, cognitive impairment, pregnancy, or who previously declined participation would not be eligible and are unlikely to benefit from enrolling.
Why it matters
Potential benefit: If successful, the telemedicine protocol could detect more vision‑threatening conditions earlier and expand access to specialist-level screening at community clinics.
How similar studies have performed: Telemedicine screening programs have previously improved diabetic retinopathy detection in primary care settings, though combining glaucoma and cataract detection in a single technology-enhanced protocol is less well established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • Speak English, Spanish, Arabic, Chinese, French, Hindi, Finnish, Albanian, Russian or Tagalog Exclusion Criteria: * significant eye pain * sudden decrease in vision within one week * binocular diplopia * cognitive impairment * pregnancy * previously declined participation
Where this trial is running
Flint, Michigan
- Hamilton Optometry Clinic — Flint, Michigan, United States (RECRUITING)
Study contacts
- Principal investigator: Paula Anne Newman-Casey, MD — University of Michigan
- Study coordinator: Suzanne Winter, MS
- Email: wsuzanne@med.umich.edu
- Phone: 734-763-6967
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Eye Diseases, Visual Impairment, Glaucoma, Eye disease screening, Glaucoma detection